The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,972,960 in first-year total cost, median $236,360.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IMM-R (90)]4
- Lung Cellular, Molecular, and Immunobiology Study Section[LCMI]2
- Biodata Management and Analysis Study Section[BDMA]1
- Cellular and Molecular Immunology - A Study Section[CMIA]1
- Immunity and Host Defense Study Section[IHD]1
Most frequent institutions
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2
- UNIV OF MASSACHUSETTS MED SCH WORCESTER2
- UNIVERSITY OF ALABAMA AT BIRMINGHAM2
- UNIVERSITY OF ROCHESTER2
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | High-density flagellin-displayed virus-like particle for universal influenza vaccine development'1R21AI156510-01A1 | CHEN, XINYUAN | UNIVERSITY OF RHODE ISLAND, RI | $196,875 | VMD |
| 2020 | Determining the induction of hemagglutinin stalk and neuraminidase antibody responses after LAIV vaccination in children1R21AI151917-01 | KRAMMER, FLORIAN | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $254,250 | ZRG1 |
| 2020 | Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus1R21AI153120-01 | SWAIN, SUSAN L | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $251,250 | CMIA |
| 2020 | Influenza host specific glycan motif identification through systems biology1R21AI144433-01A1 | WAN, XIUFENG HENRY | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $239,725 | BDMA |
| 2020 | Role of T cell-derived amphiregulin in recovery from influenza virus infection1R21AI149657-01 | ARPAIA, NICHOLAS | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $236,360 | LCMI |
| 2020 | Visualizing the resolution of innate immune responses during influenza infection1R21AI149775-01 | KIM, MINSOO | UNIVERSITY OF ROCHESTER, NY | $231,000 | III |
| 2020 | Determining the role of NLRP3 on the placement and protective potential of CD73+ BRMs post influenza infection1R21AI149271-01 | ALLIE, S RAMEEZA | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $222,750 | IHD |
| 2020 | Determine the minimal level of replication required for broad protective immunity of influenza vaccine1R21AI149648-01 | SHI, YUAN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $195,000 | VIRB |
| 2020 | Universal epitopes-based recombinant influenza vaccines1R21AI147042-01A1 | KANG, SANG-MOO | GEORGIA STATE UNIVERSITY, GA | $193,854 | ZRG1 |
| 2020 | Assessing Flu-specific Humoral Immunity in Human Lung after Ex Vivo Lung Perfusion1R21AI152006-01 | NELLORE, ANOMARANDALL, TROY D | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $185,625 | LCMI |
| 2019 | Potentiating broadly protective local immunity to influenza virus1R21AI145269-01A1 | SANT, ANDREA JANINE | UNIVERSITY OF ROCHESTER, NY | $260,771 | ZRG1 |
| 2019 | Generation of a polycistronic universal influenza virus vaccine based on rare species adenoviral vectors1R21AI146529-01 | COUGHLAN, LYNDA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $254,250 | ZRG1 |
| 2019 | Maintaining Robust T Cell Immunity For Broad Protection Against Influenza1R21AI146532-01 | SWAIN, SUSAN L | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $251,250 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.